Amil Aborts Sale of 17 Billion Dollar Deal to Bain and Advent
Brazilian health operator Amil has closed its negotiations with potential buyers Bain Capital and Advent. The company decided to keep the offer on the table for future minority investments.
Amil concluded talks to sell its business, ending a nearly six-month negotiation process. The operation had been in discussions with investment firms Bain Capital and Advent. These entities offered approximately R$ 17 billion (roughly $3.4 billion) for 100% of the company. On Thursday, Amil issued a statement to employees informing them that these talks are finished without naming specific buyers. The group stated it remains open to receiving future proposals for minority stakes in its business. This decision came after José Seripieri Jr., the former CEO who acquired the operator from UnitedHealth Group, initially sought to sell roughly 30% of the company. He defended his continued control and the current operational model he implemented. Bain and Advent had rejected his position. They intended to place Irlau Machado in charge and restructure the format used at NotreDame Intermédica before its merger with Hapvida. The foreign investors also envisioned listing the company on the Brazilian stock exchange B3.
